Higher disease rates in low sun latitudes

This randomized, placebo-controlled, clinical trial showed that the SOLIUS system effectively increased 25(OH)D concentrations in individuals with vitamin D deficiency or insufficiency, offering a safe solution for improving vitamin D status. The treatment group showed a significant increase in serum 25(OH)D concentrations, with an average increase of 10.2 ng/ml (p<0.01), compared to a decrease of 2.3 ng/ml in the control group.

A 2019 clinical pilot study published in Frontiers in Microbiology examined whether skin exposure to narrowband UVB light could influence the human gut microbiome. In healthy adults, three controlled UVB exposures over one week increased serum vitamin D levels and led to measurable changes in gut microbiota composition, particularly in participants who were vitamin D insufficient at baseline. Researchers observed increased microbial diversity and enrichment of bacterial families commonly associated with gut health, supporting the existence of a skin–gut axis through which UVB light exposure may influence intestinal homeostasis. These findings suggest that targeted UVB exposure can have systemic biological effects beyond the skin, potentially linking light exposure, vitamin D status, and microbiome health.

This large UK Biobank study of 419,007 adults found that higher habitual UV exposure was associated with significantly lower all-cause mortality, cardiovascular mortality, and non-skin cancer mortality, with clear dose-response trends. Critically, higher UV exposure showed no meaningful increase in skin cancer mortality. Counterfactual modeling quantified the trade-off directly: shifting the entire population to high UV exposure would prevent approximately 5,000 deaths from cardiovascular disease and internal cancers at the cost of only a few dozen additional skin cancer deaths - a net survival benefit ratio of roughly 100 to 1. Proteomic analysis in a 44,712-person subcohort identified the biological mechanisms as operating primarily through three non-vitamin D pathways - immunoregulatory, mucosal-barrier, and cardiorenal-neuroendocrine - confirming that the mortality benefits of UV exposure cannot be replicated by oral vitamin D supplementation. The authors conclude that current public health guidance, which frames sunlight primarily as a skin cancer hazard to be avoided, is inconsistent with the weight of evidence and warrants reappraisal. Limitations include the observational design, a White European-only cohort, and preprint status pending peer review.